Table 1.

Baseline Characteristics of the Patients (N = 60)

Demographic profile:		Liraglutide, N = 30	Dulaglutide, N = 30	P value
Male, n (%)	28(46.7%)	13 (43.3%)	15 (50%)	0.605
Female, n (%)	32 (53.3%)	17 (56.7%)	15 (50%)
Age(years), Mean ± SEM	47.75 ± 1.22	47.33 ± 1.91	48.17 ± 1.55	0.736
Height (centimeters), Mean ± SEM	161.53 ± 1.2	159.97 ± 1.52	163.10 ± 1.83	0.193
Body weight(Kg), Mean ± SEM	88.3 ± 1.68	89.43 ± 2.60	87.17 ± 2.16	0.506
Diabetes duration, (years), Mean ± SEM	6.07 ± 0.70	5.55 ± 0.94	6.59 ± 1.03	0.46
SBP(mmHg), Mean ± SEM	136.07 ± 1.84	137.83 ± 2.50	134.30 ± 2.71	0.342
DBP(mmHg), Mean ± SEM	82.1 ± 1.15	83.47 ± 1.58	80.73 ± 1.64	0.236
BMI(kg/m2), Mean ± SEM	34.99 ± 5.66	34.92 ± 0.86	32.84 ± 0.77	0.078
BMI – 25 -29.9	10 (16.67%)
BMI - 30-34.9	30 (50%)
BMI - 35-39.9	12 (20%)
BMI - ≥40	8 (13.33%)
FPG(mg/dL), Mean ± SEM	167.83 ± 7.04	160.13 ± 8.17	175.53 ± 11.45	0.278
HbA1c(%), Mean ± SEM	8.46 ± 0.17	8.49 ± 0.26	8.43 ± 0.21	0.847
On Metformin, n (%)	60 (100%)	30 (100%)	30 (100%)	1.00
On SGLT-2is, n (%)	60 (100%)	30 (100%)	30 (100%)	1.00